News

Merck announced its collaboration with Stelis Biopharma to open its first joint Process Scale-Up Lab at the Stelis Biopharma R&D Facility in the Jigani industrial estate, Bangalore.…
Read More...

FDA announced the authorization of Flourish Pediatric Esophageal Atresia Anastomosis to treat esophageal atresia in Infants. Flourish Pediatric Esophageal Atresia Anastomosis is a…
Read More...

Norgine B.V. and Merus Labs International announced that they have entered into a merger agreement under which Norgine will acquire all of the issued and outstanding common shares of…
Read More...

NantCell and NantKwest announced that the FDA has authorized NANT Cancer Vaccine for clinical trial enrollment (ClinicalTrials.gov NCT03136406). The NANT Cancer Vaccine is the first…
Read More...

NantHealth announced that Dr. Sandeep Reddy has been appointed as Chief Medical Officer. He will be responsible for overseeing education, outreach, clinical development programs, and…
Read More...

Novocure announced that it has elected Martin J. Madden to its Board of Directors in the meeting of shareholders. Mr. Madden recently retired after a 30-year career in medical device…
Read More...

Avita Medical Limited filed an IPR (Inter Partes Review) petition against US Patent No. 9,610,430 owned by Renovacare Sciences and request that all claim in the patent should be…
Read More...

LENSAR and PDL BioPharma announced the completion of LENSAR's financial restructuring with a court-approved exit plan finalized on May 11, 2017.   As part of the plan, PDL will convert…
Read More...

Catalent Pharma Solutions announced that it will commercially manufacture Lexicon Pharmaceuticals, XERMELO following the FDA  approval at its Kansas City facility. XERMELO…
Read More...

INC Research and inVentiv Health announced that their Boards of Directors have  approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock…
Read More...

Proteon Therapeutics announced that FDA has awarded Breakthrough Therapy Designation to vonapanitase (investigational treatment) for increasing arteriovenous fistula secondary patency…
Read More...

Takeda Pharmaceutical signed contract with GammaDelta Therapeutics for collaboration to develop GammaDelta Therapeutics' novel T cell platform based on the unique properties of gamma…
Read More...

ANI Pharmaceuticals, Inc. announced the launch of its first Pindolol Tablets, 5mg and 10mg. ANI's President and CEO, Arthur S. Przybyl said that they are excited to launch the first…
Read More...

BioAtla, announced that Dr. Yong Ben has been appointed as Chief Medical Officer. Dr. Yong Ben joins BioAtla with over 20 years of industry and academic experience in oncology.…
Read More...

DURECT announced that it has signed a $293 Million Agreement with Sandoz to develop and market DURECT's POSIMIR (SABER-Bupivacaine) in the United States. According to the terms of…
Read More...

Cosmo Pharmaceuticals announced that clinical trial of Eleview in comparison to a standard saline solution in subjects undergoing Endoscopic Mucosal Resection (EMR) of colonic lesions…
Read More...

U.S. FDA has granted approval for MT Pharma America, Inc. RADICAVA (edaravone), as an intravenous infusion treatment for amyotrophic lateral sclerosis (ALS).  People given RADICAVA…
Read More...

Teva Pharmaceutical and Active Biotech announced that the results from the CONCERTO trial did not meet primary endpoint. The trial was based on patients with relapsing-remitting…
Read More...

BIOLASE announced that it will be initiating a search for a Chief Financial Officer as it has accepted the resignation of recent Chief Financial Officer Mark J. Nelson. Until a…
Read More...

Opsis Therapeutics announced that their executive leadership team has approved its scientific advisory board (SAB) responsible to advise on the development and advancement to the…
Read More...